the new anti-epileptic Keppra

Lundbeck Canada will soon market the new anti-epileptic Keppra.

Keppra (levetiracetam) is approved to be added to other antiepileptic drugs to control seizures.

Keppra has several advantages. It has no significant drug interactions...and doesn't require lab monitoring.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote